You just read:

Daiichi Sankyo Presents Positive Results of the ENTRUST-AF PCI Study of LIXIANA®▼ (edoxaban) in Patients with Atrial Fibrillation

News provided by

Daiichi Sankyo Company, Limited

Sep 04, 2019, 02:00 ET